Research Associates of New York
New York, 10075, United States
NCT Number: NCT00778193
Gastroduodenal ulcers are extremely common in the community today. Though much has been written and observed concerning how ulcers form, not much has been described in the human model concerning how these ulcers heal. As numerous patients already suffer from gastrointestinal ulcers, further clarification of ulcer healing would be valuable in the treatment and management of these patients. The goal of this study is to investigate the effects of naproxen, aspirin, celecoxib, and clopidogrel on biopsy-induced gastroduodenal lesions in order to elucidate the mechanisms of ulcer healing. This single site, single-blind, randomized, placebo-controlled, one-week prospective study will examine ulcer healing through endoscopic, immunohistologic, and molecular PCR modalities.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
New York, 10075, United States
In order to assess the extent of healing of the biopsy sites, a 12-point scale was developed and validated.
After all of the procedures were complete, this scale was used to measure the effects of the study drugs on the healing of the biopsy-induced ulcers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 tablet 500mg BID for 8 days
Other names: naprosyn, naproxen sodium, Aleve, Anaprox, Miranax, Naprogesic, Naprelan, Proxen, Synflex
1 tablet 81mg QD for 8 days
Other names: ASA, Bayer
1 capsule 200mg QD for 8 days
Other names: Celebrex
Day 0: 4 tablets QD for 1 day; Days 1-7: 1 tablet QD for 7 days
Other names: Plavix
1 capsule BID for 8 days
Other names: sugar pill
Research Associates of New York, LLP
Other
A Randomized, Blinded, Placebo-Controlled Study of the Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on Gastroduodenal Healing
Acronym: Lesions2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02175186
Digestive System Diseases, Duodenal Diseases
Seoul, Songpa-Gu, South Korea
View Trial DetailsNCT03163680
Digestive System Diseases, Duodenal Diseases
Damascus, Syria
View Trial DetailsNCT00450658
Arthritis, Arthritis, Rheumatoid
View Trial DetailsNCT00797641
Digestive System Diseases, Duodenal Diseases
Aalst, Belgium
View Trial Details